Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Myklebust

Showing results (41-50 of 54) with videos related to

Pageof 6
Sort By:
Blood|January 9, 2013
High PD-1 expression and suppressed cytokine signaling distinguish T cells infiltrating follicular lymphoma tumors from peripheral T cellsJune H Myklebust, Jonathan M Irish, Joshua Brody, et al.
Blood Cancer Discovery|April 17, 2024
Disruption of KLHL6 Fuels Oncogenic Antigen Receptor Signaling in B-Cell LymphomaLeo Meriranta, Selma Sorri, Kanutte Huse, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 9, 2017
T Cells Expressing Checkpoint Receptor TIGIT Are Enriched in Follicular Lymphoma Tumors and Characterized by Reversible Suppression of T-cell Receptor SignalingSarah E Josefsson, Kanutte Huse, Arne Kolstad, et al.
Blood|January 9, 2013
Hierarchy in somatic mutations arising during genomic evolution and progression of follicular lymphomaMichael R Green, Andrew J Gentles, Ramesh V Nair, et al.
Cancer Immunology Research|January 20, 2019
TIGIT and PD-1 Mark Intratumoral T Cells with Reduced Effector Function in B-cell Non-Hodgkin LymphomaSarah E Josefsson, Klaus Beiske, Yngvild N Blaker, et al.
Scientific Reports|March 19, 2021
Karonudib has potent anti-tumor effects in preclinical models of B-cell lymphomaMorten P Oksvold, Ulrika Warpman Berglund, Helge Gad, et al.
Blood|December 25, 2016
Distinct patterns of B-cell receptor signaling in non-Hodgkin lymphomas identified by single-cell profilingJune H Myklebust, Joshua Brody, Holbrook E Kohrt, et al.
Blood Advances|April 14, 2019
Preclinical development of CD37CAR T-cell therapy for treatment of B-cell lymphomaHakan Köksal, Pierre Dillard, Sarah E Josefsson, et al.
The Journal of Biological Chemistry|June 3, 2023
Efficient chimeric antigen receptor targeting of a central epitope of CD22Nicholas Paul Casey, Clara Helena Klee, Anne Fåne, et al.
Cancer Cell|October 1, 2021
The landscape of tumor cell states and ecosystems in diffuse large B cell lymphomaChloé B Steen, Bogdan A Luca, Mohammad S Esfahani, et al.
Pageof 6

Showing results (41-50 of 54) with videos related to

Sort By:
Pageof 6
Blood|January 9, 2013
High PD-1 expression and suppressed cytokine signaling distinguish T cells infiltrating follicular lymphoma tumors from peripheral T cellsJune H Myklebust, Jonathan M Irish, Joshua Brody, et al.
Blood Cancer Discovery|April 17, 2024
Disruption of KLHL6 Fuels Oncogenic Antigen Receptor Signaling in B-Cell LymphomaLeo Meriranta, Selma Sorri, Kanutte Huse, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 9, 2017
T Cells Expressing Checkpoint Receptor TIGIT Are Enriched in Follicular Lymphoma Tumors and Characterized by Reversible Suppression of T-cell Receptor SignalingSarah E Josefsson, Kanutte Huse, Arne Kolstad, et al.
Blood|January 9, 2013
Hierarchy in somatic mutations arising during genomic evolution and progression of follicular lymphomaMichael R Green, Andrew J Gentles, Ramesh V Nair, et al.
Cancer Immunology Research|January 20, 2019
TIGIT and PD-1 Mark Intratumoral T Cells with Reduced Effector Function in B-cell Non-Hodgkin LymphomaSarah E Josefsson, Klaus Beiske, Yngvild N Blaker, et al.
Scientific Reports|March 19, 2021
Karonudib has potent anti-tumor effects in preclinical models of B-cell lymphomaMorten P Oksvold, Ulrika Warpman Berglund, Helge Gad, et al.
Blood|December 25, 2016
Distinct patterns of B-cell receptor signaling in non-Hodgkin lymphomas identified by single-cell profilingJune H Myklebust, Joshua Brody, Holbrook E Kohrt, et al.
Blood Advances|April 14, 2019
Preclinical development of CD37CAR T-cell therapy for treatment of B-cell lymphomaHakan Köksal, Pierre Dillard, Sarah E Josefsson, et al.
The Journal of Biological Chemistry|June 3, 2023
Efficient chimeric antigen receptor targeting of a central epitope of CD22Nicholas Paul Casey, Clara Helena Klee, Anne Fåne, et al.
Cancer Cell|October 1, 2021
The landscape of tumor cell states and ecosystems in diffuse large B cell lymphomaChloé B Steen, Bogdan A Luca, Mohammad S Esfahani, et al.
Pageof 6